These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1535 related articles for article (PubMed ID: 33115406)

  • 21. The Association Between Psoriasis and Risk of Cardiovascular Disease: A Mendelian Randomization Analysis.
    Gao N; Kong M; Li X; Zhu X; Wei D; Ni M; Wang Y; Hong Z; Dong A
    Front Immunol; 2022; 13():918224. PubMed ID: 35844511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causality between migraine and cardiovascular disease: a bidirectional Mendelian randomization study.
    Duan X; Du X; Zheng G; Zhou X; Tan N; Li G; Liu B; Zhu M; Ke T; Liao C
    J Headache Pain; 2024 Aug; 25(1):130. PubMed ID: 39135164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating α-Klotho Levels in Relation to Cardiovascular Diseases: A Mendelian Randomization Study.
    Sun X; Chen L; He Y; Zheng L
    Front Endocrinol (Lausanne); 2022; 13():842846. PubMed ID: 35197934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causal Associations Between Circulating Adipokines and Cardiovascular Disease: A Mendelian Randomization Study.
    Chen D; Zhang Y; Yidilisi A; Xu Y; Dong Q; Jiang J
    J Clin Endocrinol Metab; 2022 May; 107(6):e2572-e2580. PubMed ID: 35134201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating vitamin C and the risk of cardiovascular diseases: A Mendelian randomization study.
    Zhu J; Ling Y; Tse LA; Kinra S; Li Y
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2398-2406. PubMed ID: 34088583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causal associations between circulation β-carotene and cardiovascular disease: A Mendelian randomization study.
    Liu S; Wu Q; Wang S; He Y
    Medicine (Baltimore); 2023 Dec; 102(48):e36432. PubMed ID: 38050227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.
    Au Yeung SL; Luo S; Schooling CM
    Diabetologia; 2019 Sep; 62(9):1638-1646. PubMed ID: 31161347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using Mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants.
    Borges MC; Haycock PC; Zheng J; Hemani G; Holmes MV; Davey Smith G; Hingorani AD; Lawlor DA
    BMC Med; 2022 Jun; 20(1):210. PubMed ID: 35692035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study.
    Rosoff DB; Davey Smith G; Mehta N; Clarke TK; Lohoff FW
    PLoS Med; 2020 Dec; 17(12):e1003410. PubMed ID: 33275596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic insights into the role of cathepsins in cardiovascular diseases: a Mendelian randomization study.
    Zeng R; Zhou Z; Liao W; Guo B
    ESC Heart Fail; 2024 Oct; 11(5):2707-2718. PubMed ID: 38714485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Circulating Branched-Chain Amino Acids with Cardiovascular Diseases: A Mendelian Randomization Study.
    Xu H; Wang X; Geng G; Xu X; Liu L; Zhang Y; Wang Z; Wang L; Li Y
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Sclerosis and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study.
    Yang F; Hu T; He K; Ying J; Cui H
    Front Immunol; 2022; 13():861885. PubMed ID: 35371017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Liability to Depression and Risk of Coronary Artery Disease, Myocardial Infarction, and Other Cardiovascular Outcomes.
    Lu Y; Wang Z; Georgakis MK; Lin H; Zheng L
    J Am Heart Assoc; 2021 Jan; 10(1):e017986. PubMed ID: 33372528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis.
    Wang S; Zha L; Chen J; Du D; Liu D; Zhong M; Shang R; Sun D; Sun C; Jin E
    Eur J Med Res; 2022 Oct; 27(1):211. PubMed ID: 36303257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic liability to asthma and risk of cardiovascular diseases: A Mendelian randomization study.
    Chen H; Chen W; Zheng L
    Front Genet; 2022; 13():879468. PubMed ID: 35957680
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetically predicted retinal vascular occlusion in relation to cardiovascular diseases: A bidirectional two-sample Mendelian randomization analysis.
    Zhang J; Pan Y; Yang H; Hu S; Zheng S; He T
    Ann Hum Genet; 2024 Jul; 88(4):336-348. PubMed ID: 38369935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causality of genetically proxied immunophenotypes on cardiovascular diseases: a Mendelian randomization study.
    Wang X; Cheng H; Feng M; Jiang B; Ren C; Chen Q; Zhi X; Li Y
    Front Immunol; 2024; 15():1344773. PubMed ID: 38887301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically predicted high serum sex hormone-binding globulin levels are associated with lower ischemic stroke risk: A sex-stratified Mendelian randomization study.
    Sun W; Wang Y; Li C; Yao X; Wu X; He A; Zhao B; Huang X; Song H
    J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107686. PubMed ID: 38522757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
    Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 77.